These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23585648)

  • 1. Ghost- and guest-authored pharmaceutical industry-sponsored studies: abuse of academic integrity, the peer review system, and public trust.
    Flaherty DK
    Ann Pharmacother; 2013; 47(7-8):1081-3. PubMed ID: 23585648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The corporate coauthor.
    Fugh-Berman A
    J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to finger point or fix? An invitation to join ongoing efforts to promote ethical authorship and other good publication practices.
    Woolley KL; Gertel A; Hamilton CW; Jacobs A; Snyder GP;
    Ann Pharmacother; 2013; 47(7-8):1084-7. PubMed ID: 23800751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
    Ross JS; Hill KP; Egilman DS; Krumholz HM
    JAMA; 2008 Apr; 299(15):1800-12. PubMed ID: 18413874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impugning the integrity of medical science: the adverse effects of industry influence.
    DeAngelis CD; Fontanarosa PB
    JAMA; 2008 Apr; 299(15):1833-5. PubMed ID: 18413880
    [No Abstract]   [Full Text] [Related]  

  • 6. Publication ethics and the ghost management of medical publication.
    Sismondo S; Doucet M
    Bioethics; 2010 Jul; 24(6):273-83. PubMed ID: 19222451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrity of Authorship and Peer Review Practices: Challenges and Opportunities for Improvement.
    Misra DP; Ravindran V; Agarwal V
    J Korean Med Sci; 2018 Nov; 33(46):e287. PubMed ID: 30416407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to ensure our readers' trust: the proper attribution of authors and contributors.
    Liesegang TJ; Albert DM; Schachat AP
    Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
    [No Abstract]   [Full Text] [Related]  

  • 9. Authorship policy.
    Novack GD
    Am J Ophthalmol; 2009 Jan; 147(1):184; author reply 184-5. PubMed ID: 19100357
    [No Abstract]   [Full Text] [Related]  

  • 10. Ghost marketing: pharmaceutical companies and ghostwritten journal articles.
    Moffatt B; Elliott C
    Perspect Biol Med; 2007; 50(1):18-31. PubMed ID: 17259673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haunted manuscripts: ghost authorship in the medical literature.
    Ngai S; Gold JL; Gill SS; Rochon PA
    Account Res; 2005; 12(2):103-14. PubMed ID: 16220624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The journals must honestly tell who is doing the job].
    Bergström R
    Lakartidningen; 2008 May 7-13; 105(19):1406-7. PubMed ID: 18574981
    [No Abstract]   [Full Text] [Related]  

  • 13. Meeting our ethical obligations in medical publishing: responsibilities of editors, authors, and readers of peer-reviewed journals.
    Albert DM; Liesegang TJ; Schachat AP
    Arch Ophthalmol; 2005 May; 123(5):684-6. PubMed ID: 15883290
    [No Abstract]   [Full Text] [Related]  

  • 14. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 15. The Disposable Author: How Pharmaceutical Marketing Is Embraced within Medicine's Scholarly Literature.
    Matheson A
    Hastings Cent Rep; 2016 Jul; 46(4):31-7. PubMed ID: 27417868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disclosure of conflicts of interest in biomedical publications.
    Miller DR
    Can J Anaesth; 2008 May; 55(5):265-7, 267-9. PubMed ID: 18451113
    [No Abstract]   [Full Text] [Related]  

  • 17. Developing good scientific publishing practices: one pharmaceutical company's perspective.
    Dowsett SA; Van Campen LE; Bednar LA
    Curr Med Res Opin; 2010 Jun; 26(6):1249-54. PubMed ID: 20350148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey.
    Wager E; Woolley K; Adshead V; Cairns A; Fullam J; Gonzalez J; Grant T; Tortell S
    BMJ Open; 2014 Apr; 4(4):e004780. PubMed ID: 24747794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
    Norris RA
    Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261
    [No Abstract]   [Full Text] [Related]  

  • 20. The ethics of peer review: What to know before saying "yes".
    Siedlecki SL
    Nurs Manage; 2016 Jul; 47(7):44-8. PubMed ID: 27351121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.